Dr Haddad of spoke about lasofoxifene, a new generation SERM that has shown promising results in animal models and has been fast tracked by . ELAINE trial just opened and first pt enrolled today #6thMBCC
New #breastcancer clinical trial on Open-label Trial of Lasofoxifene vs. Fulvestrant in Advanced or Metastatic ER+/HER2− Breast Cancer With an ESR1 Mutation